Investigating Risk Factors of Ependymomas
Molecular epidemiologist Michael Scheurer, Ph.D., at Baylor College of Medicine in Houston, is studying the genetic profiles of ependymoma patients to unravel the causes of the rare disease and the potential for targeted therapies.
“If we can identify factors that predispose people to ependymoma, we could ultimately intervene to prevent the tumor from developing,” says Dr. Scheurer.
Dr. Scheurer is leading a
Risk Project with Terri Armstrong, Ph.D., Senior Investigator of the Patient Outcomes Program for the CERN Foundation, to investigate risk factors associated with ependymoma.
The Risk Project is an extension of Dr. Armstrong’s Ependymoma Outcomes Project, an online survey for adult and pediatric ependymoma patients and the parents of pediatric patients to learn what life is like for people with ependymoma before, during and after treatment.
While the Ependymoma Outcomes Project analyzes the patient’s experience with ependymoma, the Risk Project aims to answer why ependymoma developed in the first place, explains Dr. Scheurer.